What are the names of the generic insulin lispro prefilled injection pens?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Generic Insulin Lispro Prefilled Injection Pens

The generic insulin lispro prefilled injection pens available in the U.S. are the "Lispro follow-on product" U-100 prefilled pen and the "Lispro-aabc" (insulin lispro-aabc) prefilled pens in both U-100 and U-200 concentrations.

Available Generic Formulations

Based on the most recent American Diabetes Association guidelines 1, 2, 3, the generic insulin lispro prefilled pens include:

Lispro Follow-On Product

  • U-100 prefilled pen - This is the most affordable generic option with a median cost of $151 per 1,000 units (AWP) or $121 (NADAC) 1

Lispro-aabc (Insulin Lispro-aabc)

The FDA-approved insulin lispro-aabc is marketed under the brand name LYUMJEV and comes in multiple prefilled pen options 4:

  • LYUMJEV KwikPen (U-100): Standard prefilled pen delivering 100 units/mL
  • LYUMJEV Junior KwikPen (U-100): Delivers 0.5 to 30 units in 0.5-unit increments, designed for patients requiring finer dose adjustments 5
  • LYUMJEV Tempo Pen (U-100): Another U-100 prefilled pen option
  • LYUMJEV KwikPen (U-200): Concentrated formulation delivering 200 units/mL

Cost Considerations

The generic "Lispro follow-on product" U-100 prefilled pen offers significant cost savings compared to branded options, with pricing approximately 40-50% lower than branded insulin lispro pens 2, 3. The median NADAC cost is $121 per 1,000 units compared to $102 for branded lispro U-100 prefilled pens (when generic pricing is used) 2.

Clinical Equivalence

These generic formulations demonstrate similar pharmacokinetics and pharmacodynamics to branded insulin lispro 6. The lispro-aabc formulation has been shown to be safe and effective when used in insulin pumps and standard injection devices, with no clinically significant differences in infusion set occlusions or hypoglycemia rates compared to branded products 6.

Device Features

All prefilled insulin lispro pens share common advantages 7, 8:

  • Combine vial and syringe into a single device
  • Allow push-button injections
  • Vary in dosing increments (0.5 to 2-unit increments depending on the pen)
  • Recommended for use with BD (Becton, Dickinson and Company) insulin pen needles 4

The Junior KwikPen specifically addresses the needs of patients requiring half-unit dosing, which is particularly valuable for children, adolescents, insulin-sensitive adults, and pregnant women 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.